Abstract
The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that "participation of pharmacists in cancer chemotherapy" was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.
| Original language | English |
|---|---|
| Pages (from-to) | 629-642 |
| Number of pages | 14 |
| Journal | Yakugaku Zasshi |
| Volume | 126 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2006 Aug 11 |
| Externally published | Yes |
Fingerprint
Keywords
- Cancer chemotherapy
- Medical care team
- Patient participation
- Sharing patient information
- Side effects monitoring
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science
Cite this
Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information. / Kawazoe, Hitoshi; Kubo, Tomomi; Iihara, Naomi; Doi, Chiaki; Okujyoh, Makiko; Fukuoka, Noriyasu; Fujimoto, Satoshi; Kanaji, Nobuhiro; Bandoh, Shuji; Ishida, Toshihiko; Takiguchi, Yoshiharu; Houchi, Hitoshi.
In: Yakugaku Zasshi, Vol. 126, No. 8, 11.08.2006, p. 629-642.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information
AU - Kawazoe, Hitoshi
AU - Kubo, Tomomi
AU - Iihara, Naomi
AU - Doi, Chiaki
AU - Okujyoh, Makiko
AU - Fukuoka, Noriyasu
AU - Fujimoto, Satoshi
AU - Kanaji, Nobuhiro
AU - Bandoh, Shuji
AU - Ishida, Toshihiko
AU - Takiguchi, Yoshiharu
AU - Houchi, Hitoshi
PY - 2006/8/11
Y1 - 2006/8/11
N2 - The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that "participation of pharmacists in cancer chemotherapy" was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.
AB - The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that "participation of pharmacists in cancer chemotherapy" was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.
KW - Cancer chemotherapy
KW - Medical care team
KW - Patient participation
KW - Sharing patient information
KW - Side effects monitoring
UR - http://www.scopus.com/inward/record.url?scp=33746793252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746793252&partnerID=8YFLogxK
U2 - 10.1248/yakushi.126.629
DO - 10.1248/yakushi.126.629
M3 - Article
C2 - 16880721
AN - SCOPUS:33746793252
VL - 126
SP - 629
EP - 642
JO - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
JF - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
SN - 0031-6903
IS - 8
ER -